Prolactin levels in risperidone treatment of first episode schizophrenia.
| Autoři | |
|---|---|
| Rok publikování | 2003 |
| Druh | Článek v odborném periodiku |
| Časopis / Zdroj | International Journal of Psychiatry in Clinical Practice |
| Fakulta / Pracoviště MU | |
| Citace | |
| Obor | Psychiatrie, sexuologie |
| Klíčová slova | prolactin; risperidone; schizophrenia |
| Popis | Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy. |
| Související projekty: |